Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Today, the U.S. Supreme Court issued a stay on lower court rulings that attempted to block the Food and Drug Administration’s (FDA) approval of Mifepristone, meaning access to the medication will remain in place throughout the country including Planned Parenthood Great Plains’ (PPGP) Kansas health centers. The decision comes after the Supreme Court granted a temporary stay last week.

In the case, Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, Judge Matthew Kacsmaryk took unprecedented action on April 7, to block FDA approval of Mifepristone. The Fifth Circuit Court of Appeals then kept part of the ruling in place but removed certain restrictions on the drug. First approved more than 20 years ago, Mifepristone is safe and effective, and has been used by more than five million people in the United States.

In response to today’s ruling, PPGP will continue to offer medication abortion using Mifepristone as part of a two-drug regimen at its Kansas health centers.

Statement from Emily Wales, president and CEO, Planned Parenthood Great Plains:

"This is a relief for our patients who, amid the uncertainty of the last two weeks, have wondered what their care would look like when they made it to their appointment. For them, this confusion was yet another burden in accessing medication abortion that should be available, regardless of where they live. But to be at the point where the high court had to weigh in on a drug that has been safely used by millions of people should be chilling for all Americans who trust science to guide best practice medicine. While the fight for equitable access to care is far from over this was an important step.”


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.